Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer
Prostate-specific membrane antigen (PSMA) is highly expressed on most prostate cancer
(PCa) cells, and several PSMA ligands for PET imaging are now available worldwide. 68Ga …
(PCa) cells, and several PSMA ligands for PET imaging are now available worldwide. 68Ga …
Recent advances of PET imaging in clinical radiation oncology
Radiotherapy and radiation oncology play a key role in the clinical management of patients
suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast …
suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast …
[HTML][HTML] Radiomics in prostate cancer imaging for a personalized treatment approach-current aspects of methodology and a systematic review on validated studies
SKB Spohn, AS Bettermann, F Bamberg… - Theranostics, 2021 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is one of the most frequently diagnosed malignancies of men in the
world. Due to a variety of treatment options in different risk groups, proper diagnostic and …
world. Due to a variety of treatment options in different risk groups, proper diagnostic and …
Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis
Background The analysis aimed to compare the radiotracers [68 Ga]-Ga-PSMA-11 and [18
F]-F-PSMA-1007 intraindividually in terms of malignant lesions, mi (molecular-imaging) TNM …
F]-F-PSMA-1007 intraindividually in terms of malignant lesions, mi (molecular-imaging) TNM …
[HTML][HTML] [68Ga] Ga-PSMA-11 in prostate cancer: a comprehensive review
Imaging of the prostate-specific membrane antigen (PSMA) has become an important tool
for managing patients with recurrent prostate cancer, and one of the most frequently …
for managing patients with recurrent prostate cancer, and one of the most frequently …
Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with 18F-PSMA-1007 PET: comparison among different …
F Yao, S Bian, D Zhu, Y Yuan, K Pan, Z Pan, X Feng… - La radiologia …, 2022 - Springer
Background PET-based radiomics features could predict the biological characteristics of
primary prostate cancer (PCa). However, the optimal thresholds to predict the biological …
primary prostate cancer (PCa). However, the optimal thresholds to predict the biological …
Uncovering the invisible—prevalence, characteristics, and radiomics feature–based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 …
Abstract Introduction Primary prostate cancer (PCa) can be visualized on prostate-specific
membrane antigen positron emission tomography (PSMA-PET) with high accuracy …
membrane antigen positron emission tomography (PSMA-PET) with high accuracy …
Intraprostatic tumor segmentation on PSMA PET images in patients with primary prostate cancer with a convolutional neural network
D Kostyszyn, T Fechter, N Bartl, AL Grosu… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Accurate delineation of the intraprostatic gross tumor volume (GTV) is a prerequisite for
treatment approaches in patients with primary prostate cancer (PCa). Prostate-specific …
treatment approaches in patients with primary prostate cancer (PCa). Prostate-specific …
[HTML][HTML] Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer
Purpose With the increased use of focal radiation dose escalation for primary prostate
cancer (PCa), accurate delineation of gross tumor volume (GTV) in prostate-specific …
cancer (PCa), accurate delineation of gross tumor volume (GTV) in prostate-specific …
Comparison of multiparametric magnetic resonance imaging with prostate-specific membrane antigen positron-emission tomography imaging in primary prostate …
Y Zhao, BS Simpson, N Morka, A Freeman, A Kirkham… - Cancers, 2022 - mdpi.com
Simple Summary Multiparametric magnetic-resonance imaging (mpMRI) is a routinely used
imaging modality for diagnosing prostate cancer but misses 10–20% of prostate tumours …
imaging modality for diagnosing prostate cancer but misses 10–20% of prostate tumours …